Portfolio Manager Factsheet

October 2018

Large cap pharma stocks fared reasonably well down only 1.0%; this sector represents the Trust’s largest underweight position. Small cap biotech stocks were down 15.6%; this sector represents the Trust’s largest overweight position; other strategic overweights in the Company is large cap biotech, down 12.7%; and Emerging market healthcare, down 12.5%. 

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.